Literature DB >> 22782972

The occurrence of cardiovascular disease during 5-year follow-up in patients with idiopathic atrial fibrillation.

B Weijs1, C B de Vos, R G Tieleman, F E C M Peeters, I Limantoro, A A Kroon, E C Cheriex, R Pisters, H J G M Crijns.   

Abstract

AIMS: Idiopathic atrial fibrillation (AF) may be an expression of as yet undetected underlying heart disease. We found it useful for clinical practice to study the long-term development of cardiovascular disease (CVD) in patients diagnosed with idiopathic AF. METHODS AND
RESULTS: Forty-one consecutive idiopathic AF patients (56 ± 10 years, 66% male) were compared with 45 healthy control patients in permanent sinus rhythm. Patients were free of hypertension, antihypertensive and antiarrhythmic drugs, diabetes, congestive heart failure, coronary artery or peripheral vascular disease, previous stroke, thyroid, pulmonary and renal disease, and structural abnormalities on echocardiography. Baseline characteristics and echocardiographic parameters were equal in AF cases and controls. During a mean follow-up of 66 ± 11 months, CVD occurred significantly more often in idiopathic AF patients compared with controls (49 vs. 20%, P= 0.006). Patients with idiopathic AF were significantly younger at the time of their first CV event compared with controls (59 ± 9 vs. 64 ± 5 years, P= 0.027), and had more severe disease. Multivariable Cox regression analysis revealed that age, a history of AF, and echocardiographic left ventricular wall width were significant predictors of CVD development.
CONCLUSION: Patients originally diagnosed with idiopathic AF develop CVD more often, at younger age, and with a more severe disease profile compared with healthy sinus rhythm control patients. The detection and treatment of CVD in an early stage could improve the prognosis of these patients. At present it seems prudent to regularly check idiopathic AF patients for the insidious development of CVD.

Entities:  

Mesh:

Year:  2012        PMID: 22782972     DOI: 10.1093/europace/eus203

Source DB:  PubMed          Journal:  Europace        ISSN: 1099-5129            Impact factor:   5.214


  13 in total

1.  Patients without comorbidities at the time of diagnosis of atrial fibrillation: causes of death during long-term follow-up compared to matched controls.

Authors:  Tommy Andersson; Anders Magnuson; Ing-Liss Bryngelsson; Ole Frøbert; Karin M Henriksson; Nils Edvardsson; Dritan Poçi
Journal:  Clin Cardiol       Date:  2017-08-25       Impact factor: 2.882

Review 2.  Lone AF: is There a Rationale?

Authors:  Duygu Kocyigit; Kadri Murat Gurses; Kudret Aytemir
Journal:  J Atr Fibrillation       Date:  2015-06-30

3.  Lone Atrial Fibrillation: Risk Factors, Triggers And Ablation Techniques.

Authors:  Mindy Vroomen; Laurent Pison
Journal:  J Atr Fibrillation       Date:  2015-06-30

Review 4.  Lone atrial fibrillation: does it exist?

Authors:  D George Wyse; Isabelle C Van Gelder; Patrick T Ellinor; Alan S Go; Jonathan M Kalman; Sanjiv M Narayan; Stanley Nattel; Ulrich Schotten; Michiel Rienstra
Journal:  J Am Coll Cardiol       Date:  2014-02-12       Impact factor: 24.094

5.  Characteristics and outcomes of atrial fibrillation in patients without traditional risk factors: an RE-LY AF registry analysis.

Authors:  Mariëlle Kloosterman; Jonas Oldgren; David Conen; Jorge A Wong; Stuart J Connolly; Alvaro Avezum; Salim Yusuf; Michael D Ezekowitz; Lars Wallentin; Marie Ntep-Gweth; Philip Joseph; Tyler W Barrett; Supachai Tanosmsup; William F McIntyre; Shun Fu Lee; Ratika Parkash; Guy Amit; Alex Grinvalds; Isabelle C Van Gelder; Jeff S Healey
Journal:  Europace       Date:  2020-06-01       Impact factor: 5.214

6.  Concealed Coronary Atherosclerosis In Idiopathic Paroxysmal Atrial Fibrillation is Associated with Imminent Cardiovascular Diseases.

Authors:  Eamp Dudink; B Weijs; Jglm Luermans; Fecm Peeters; S Altintas; K Vernooy; Lafg Pison; R J Haest; J A Kragten; Bljh Kietselaer; J E Wildberger; Hjgm Crijns
Journal:  J Atr Fibrillation       Date:  2020-12-31

7.  Idiopathic atrial fibrillation patients rapidly outgrow their low thromboembolic risk: a 10-year follow-up study.

Authors:  B Weijs; E A M P Dudink; C B de Vos; I Limantoro; R G Tieleman; R Pisters; E C Cheriex; J G L M Luermans; H J G M Crijns
Journal:  Neth Heart J       Date:  2019-10       Impact factor: 2.380

8.  Atrial fibrillation without comorbidities: Prevalence, incidence and prognosis (from the Framingham Heart Study).

Authors:  Eun-Jeong Kim; Xiaoyan Yin; João D Fontes; Jared W Magnani; Steve A Lubitz; David D McManus; Sudha Seshadri; Ramachandran S Vasan; Patrick T Ellinor; Martin G Larson; Emelia J Benjamin; Michiel Rienstra
Journal:  Am Heart J       Date:  2016-04-30       Impact factor: 4.749

9.  Relation of Biomarkers of Inflammation and Oxidative Stress with Hypertension Occurrence in Lone Atrial Fibrillation.

Authors:  Marija M Polovina; Miodrag C Ostojic; Tatjana S Potpara
Journal:  Mediators Inflamm       Date:  2015-07-01       Impact factor: 4.711

10.  Negative predictive value of SPECT for the occurrence of MACE in a medium-sized clinic in the Netherlands.

Authors:  M J Bom; J M B Manders; R Uijlings; E A Badings; F M A C Martens
Journal:  Neth Heart J       Date:  2014-04       Impact factor: 2.380

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.